Itero Biopharmaceuticals News
Most Popular Itero Biopharmaceuticals Story
Emerging Drug Developer: Itero Biopharmaceuticals
Itero adopts a ‘high-tech' development strategy Bryan Lawlis, Ph.D, has found a niche in the biotech industry in which he plans to grow a new biotech company. But don't ask him for the inside... Read more...
Latest Headlines
- June 16, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
